Publications by authors named "Alessandra Risso"

Claim this Profile
P
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries.
Zobair M Younossi, James M Paik, Jeffrey V Lazarus, Patrizia Burra, Yuichiro Eguchi, Alessandra Risso

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients.
Enrico Derenzini, Angela Gueli, Alessandra Risso, Riccardo Bruna, Daniela Gottardi

Hematol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development.
Gian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, Patrizia Carucci, Emanuela Rolle, Alessandra Risso

Biology (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study.
Alessia Ciancio, Davide Giuseppe Ribaldone, Matteo Spertino, Alessandra Risso, Debora Ferrarotti

Biomedicines· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
Aurora Nicolosi, Silvia Gaia, Alessandra Risso, Chiara Rosso, Emanuela Rolle

Minerva Gastroenterol (Torino)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease.
Gian Paolo Caviglia, Aurora Nicolosi, Maria Lorena Abate, Patrizia Carucci, Chiara Rosso, Alessandra Risso

Curr Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy.
Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Silvia Gaia, Emanuela Rolle, Alessandra Risso

Curr Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
Silvia Gaia, Michela Ciruolo, Davide Giuseppe Ribaldone, Emanuela Rolle, Enrica Migliore, Alessandra Risso

Curr Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology.
Gian Paolo Caviglia, Michela Ciruolo, Maria Lorena Abate, Patrizia Carucci, Emanuela Rolle, Alessandra Risso

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma.
Gian Paolo Caviglia, Michela Ciruolo, Antonella Olivero, Patrizia Carucci, Emanuela Rolle, Alessandra Risso

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Donor and Recipient Gender on Telomere Maintenance after Umbilical Cord Blood Cell Transplantation: A Study by the Gruppo Italiano Trapianto Di Midollo Osseo.
Enrico Derenzini, Alessandra Risso, Marco Ruella, Tiziana Spatola, Giuseppe Milone

Biol Blood Marrow Transplant· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical heterogeneity in a family with mutation, dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome in first cousins.
Cristina Olivieri, Anna Mondino, Matteo Chinello, Alessandra Risso, Enrico Finale

Pediatr Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation.
Silvia Gaia, Antonella Olivero, Antonina Smedile, Marco Ruella, Maria Lorena Abate, Alessandra Risso

Hepatol Int· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy.
Marco Ruella, Silvia Salmoiraghi, Alessandra Risso, Alessandra Carobbio, Stefano Buttiglieri

Exp Hematol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multipotent mesenchymal stromal stem cell expansion by plating whole bone marrow at a low cellular density: a more advantageous method for clinical use.
Katia Mareschi, Deborah Rustichelli, Roberto Calabrese, Monica Gunetti, Fiorella Sanavio, Alessandra Risso

Stem Cells Int· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The aging effect of chemotherapy on cultured human mesenchymal stem cells.
Stefano Buttiglieri, Marco Ruella, Alessandra Risso, Tiziana Spatola, Lorenzo Silengo

Exp Hematol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
Anna Guidetti, Carmelo Carlo-Stella, Marco Ruella, Rosalba Miceli, Lilli Devizzi, Alessandra Risso

Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis